Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LYSHAWN XATIY PHOMMAKHOTH

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1306627260
CMS profile
11600146
Location
SACRAMENTO, CA

General Payments · PY2024

$304.65

  • Reported across 16 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$304.65

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $304.65 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $70.30 3
Acerta Pharma LLC $58.69 4
Corcept Therapeutics $48.61 2
GlaxoSmithKline, LLC. $42.43 2
PFIZER INC. $32.34 2
Novo Nordisk AS $18.10 1
Takeda Pharmaceuticals U.S.A., Inc. $17.40 1
IRONWOOD PHARMACEUTICALS, INC $16.78 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $304.65 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $14.55 05/24/2024 Food and Beverage Undisputed 01/23/2026 1105654074 CMS
AstraZeneca Pharmaceuticals LP $14.39 06/28/2024 Food and Beverage Undisputed 01/23/2026 1104647245 CMS
AstraZeneca Pharmaceuticals LP $14.27 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105794986 CMS
AstraZeneca Pharmaceuticals LP $15.48 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104286668 CMS
Corcept Therapeutics $16.57 10/30/2024 Food and Beverage Undisputed 01/23/2026 1117766803 CMS
Corcept Therapeutics $32.04 11/20/2024 Food and Beverage Undisputed 01/23/2026 1117766873 CMS
GlaxoSmithKline, LLC. $25.24 06/01/2024 Food and Beverage Undisputed 01/23/2026 1116323908 CMS
GlaxoSmithKline, LLC. $17.19 10/16/2024 Food and Beverage Undisputed 01/23/2026 1115899458 CMS
IRONWOOD PHARMACEUTICALS, INC $16.78 08/09/2024 Food and Beverage Undisputed 01/23/2026 1153753702 CMS
Lilly USA, LLC $21.17 06/14/2024 Food and Beverage Undisputed 01/23/2026 1135828935 CMS
Lilly USA, LLC $31.24 07/02/2024 Food and Beverage Undisputed 01/23/2026 1135806843 CMS
Lilly USA, LLC $17.89 11/02/2024 Food and Beverage Undisputed 01/23/2026 1135770190 CMS
Novo Nordisk Inc $18.10 09/04/2024 Food and Beverage Undisputed 01/23/2026 1100576362 CMS
PFIZER INC. $17.34 10/04/2024 Food and Beverage Undisputed 01/23/2026 1131987991 CMS
PFIZER INC. $15.00 10/09/2024 Food and Beverage Undisputed 01/23/2026 1130885738 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.40 09/18/2024 Food and Beverage Undisputed 01/23/2026 1137807723 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.